Nanotechnology offers different ways to fight COVID-19 pandemic with antivirals

Nanotechnology offers different ways to fight COVID-19 pandemic with antivirals
Spread the love

A brand new wave of funding specializes in antiviral nanomaterials as pandemic countermeasures.

A flurry of as much as date papers highlights rising hobby in approaches that make employ of nanomaterials as antiviral countermeasures. In contrast with conventional small molecules or antibodies that inhibit viral replication or mobile entry, nanotechnology offers drug builders virus binders, cell-membrane decoys or viral-envelope inhibitors that would moreover simply complement conventional antiviral therapies. With the lend a hand of an influx of funding spurred by the COVID-19 pandemic, some researchers hope that these materials could well shortly switch in the direction of clinical translation.

On this artist’s influence, a DNA shell traps a virus to end it from interacting with host cells.
Credit: Elena-Marie Willner / Dietz Lab / TUM

Nanomaterials bear already accomplished a key role within the fight against SARS-CoV-2. The Pfizer–BioNtech and Moderna vaccines every rely on lipid nanoparticles to carry mRNA into cells. Nanoparticles are also showing promise as autos for small-molecule antiviral treatment, constructing on decades of progress with nanoscale drug-supply programs.

Now the urgency of the COVID-19 pandemic is generating hobby in therapeutic nanomaterials that can themselves live viruses in their tracks, rather then appropriate performing as supply autos for treatment or vaccines. “A majority of these nanomaterials are being developed to rob with the virus particles straight away, both disrupting them or binding to them,” says Joshua A. Jackman of Sungkyunkwan College in South Korea.

No longer like conventional therapeutics, which have a tendency to attempt a explicit viral species and could moreover simply lose their efficacy as the virus accumulates mutations, antiviral nanomaterials aim chemical and physical properties overall to many forms of virus. Just a few recent papers bear described antiviral strategies that rely on DNA-basically based solely nanostructures to trap viruses or employ modified polymers that act as cell membrane decoys; others destroy aside viral membranes to end an infection. A majority of these nanomaterials could moreover simply supply advantages within the context of pandemic countermeasures, as they can doubtlessly be formulated instant and bear disclose across a large vary of virus households.

Much of this work is accumulated confined to academic labs, even supposing a handful of companies are constructing antiviral nanomaterials (Table 1). Nonetheless the ravages of COVID-19—and the clear desire to prepare for future viral pandemics—are opening up unique opportunities.

Table 1 Chosen companies pursuing antiviral nanomaterials

In June, to illustrate, the Biden administration launched the Antiviral Program for Pandemics, with $3 billion for examine into new antivirals that can cope with SARS-CoV-2 and other viruses with pandemic capability. “This new funding circulation will positively stimulate and provides a purchase to more examine and fashion within the distance of antiviral nanomaterials,” says Liangfang Zhang on the College of California, San Diego. “COVID has if truth be told modified the panorama, we see that we if truth be told need more ready-made alternate choices for rising viruses.”

Because many viruses rely on glycoproteins on their surface to bind to molecules on host cells, nanomaterials that mimic these mobile attachment components can doubtlessly act as antivirals. Zhang is making ‘nanosponges’ that employ this implies to intercept viruses. To compose the nanosponges, Zhang’s personnel starts with human cells equivalent to red blood cells or macrophages. After taking out the contents of the cell to amble away handiest the membrane, they destroy the membrane into hundreds of shrimp vesicles roughly 100 nanometers large. Then they add nanoparticles fabricated from a biocompatible and biodegradable polymer, equivalent to poly(lactic-co-glycolic acid). Every nanoparticle becomes coated with a cell membrane, forming a stable core-shell constructing that acts as a decoy of a human cell. The nanosponges then employ binding components on their membranes to encompass a virus and forestall it from coming into host cells.

These nanosponges are efficient against a total lot of viruses and bacteria in vivo, and Zhang’s San Diego-basically based solely stir-out firm Cellics Therapeutics plans to open up a clinical trial subsequent 365 days of its lead candidate, a nanosponge carrying a red blood cell membrane that is efficient against methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Cellics is also using macrophage membranes to invent the same nanosponges with antiviral disclose. “There are a unheard of choice of diversified forms of virus, and each virus could moreover simply bear diversified variants,” Zhang says, “nonetheless no topic that, in converse to contaminate folks they desire to work along with the host’s cells thru receptors.”

Last 365 days, Zhang found out that a mobile nanosponge coated in membranes derived from human lung epithelial kind II cells or human macrophages were every ready to trap SARS-CoV-2 and forestall an infection in vitro. The membranes on these nanosponges sport angiotensin-changing enzyme 2 (ACE2) and CD147, to which SARS-CoV-2 binds throughout an infection. Zhang’s personnel also has unpublished outcomes from an in vivo scrutinize with mice, showing efficacy against the coronavirus and no evidence of toxicity.

Starpharma, headquartered in Abbotsford, Melbourne, Australia, is also mimicking host cells to strive against viruses. It makes artificial polymers with a branched constructing, identified as dendrimers, which could well be roughly 3–4 nanometers large. The outer surface of every dendrimer is lined in naphthalene disulfonate groups, an akin to the heparan sulfate proteoglycans found out on host cell membranes, which many viruses stick to.

Starpharma already has merchandise on the market that make employ of a dendrimer referred to as SPL7013 as an exterior barrier against viruses and bacteria. SPL7013 is conventional in VivaGel, a lubricant in condoms, to illustrate. Earlier this 365 days, Starpharma launched Viraleze, a large-spectrum antiviral nasal spray containing SPL7013, which is registered for sale as a scientific instrument in Europe and India. Nonetheless, gross sales of Viraleze within the UK were halted in June after the UK Medicines and Healthcare merchandise Regulatory Company raised issues in regards to the product’s marketing claims.

In August, the firm unveiled examine showing that Viraleze steer clear off SARS-CoV-2 an infection in a mouse mannequin. Administering the nasal spray earlier than and after exposure to SARS-CoV-2 reduced viral loads within the animals’ blood, lungs and trachea by bigger than 99%. The firm says that a clinical safety scrutinize, which has no longer but been seek files from reviewed, showed that the dendrimer in Viraleze used to be no longer absorbed within the physique and caused no critical facet effects.

Jackie Fairley, Starpharma’s CEO, says that the firm’s dendrimer could well showcase precious in future pandemics. “It’s a stable raw topic fabric that could well be formulated into a product instant, and it has disclose across a extremely large spectrum of viruses,” she says. In the length in-between, the firm plans to compose greater animals examine to verify the disclose of Viraleze against SARS-CoV-2.

Some antiviral nanomaterials are precisely formed to trap viruses. In Germany, Rainer Haag of the Free College of Berlin is overlaying silica nanoparticles with 5–10-nm-unheard of spikes that mesh neatly between a virus’ surface glycoproteins. The spikes could even be decorated with sialic acid sugars to give a purchase to binding, or with antiviral compounds equivalent to zanamivir. “By matching the morphology of the virus, we maximize the binding,” says Chuanxiong Nie, a postdoc in Haag’s personnel who has been leading the work. In vitro experiments showed that the particles steer clear off an infection of cells with influenza A virulent disease, and the personnel now hopes to invent spiky nanoparticles with disclose against SARS-CoV-2. The Berlin College Alliance is supporting the work as allotment of a €1.8-million ($2.3 million) grant awarded last 365 days.

Star-formed DNA scaffolds supply one other capability capacity. Xing Wang on the College of Illinois at Urbana-Champaign has constructed such buildings carrying DNA aptamers able to binding to antigens at loads of components on the surface of dengue fever virus. The physical bulk of the DNA star, and its detrimental mark, end the virus from latching on to host cells, shutting down an infection. The personnel also has in vitro files, for the time being being seek files from reviewed, showing that definite DNA stars can inhibit SARS-CoV-2 an infection. Wang objectives to commercialize the DNA stars thru his stir-out firm, Atom Bioworks of Cary, North Carolina.

A build of DNA origami is being pursued by Hendrik Dietz on the Technical College of Munich. The personnel has developed shells fabricated from DNA which could well be unheard of enough to swallow a total virus total. The inner of the self-assembling icosahedral shells could even be lined with binders, equivalent to antibodies, to withhold onto trapped viruses. Dietz says that the nanoshells could well doubtlessly decrease viral load throughout acute infections.

The researchers designed triangular DNA buildings that assemble into shells of loads of types and sizes, from 90 to 300 nanometers large. By tweaking the DNA sequences within the triangular constructing blocks, they created virus-sized openings within the facet of a shell. In vitro experiments showed that these shells could well bind viruses equivalent to adeno-linked virus serotype 2 and forestall them from infecting human cells. “The finest thing about our shells is the choice of virus binders we are able to connect, and in addition that we are able to swap the virus binders very effortlessly,” says Christian Sigl, a PhD student in Dietz’s lab who accomplished the experimental work. This plan the shells could well in theory be tailor-made to bind any virus, he says. Dietz is the coordinator of a €3.9-million mission referred to as Virofight, which launched in June 2020 with funding from the European Price, to build a shell to trap SARS-CoV-2 and take a look at the approach in mice.

Some nanomaterials amble previous simply binding viruses—as a replace, they disrupt the viral membrane to end an infection. Viral genomes are encapsulated by a protein-basically based solely capsid, nonetheless in many cases, along with that of SARS-CoV-2, that capsid is lined by a phospholipid bilayer membrane, which is necessary for the virus to fuse with cell membranes. No longer like bacterial membranes, this viral envelope is obtained from the host cell membrane itself, as newly created virus particles amble away infected cells. “This envelope is excessive for an infection, and for the structural integrity of the virus,” Jackman says. “Nonetheless of us don’t necessarily ticket the lipid membrane is druggable.”

NanoViricides, basically based solely in Shelton, Connecticut, objectives to disrupt viral membranes using soluble polymer surfactants that build spherical micelles. These nanoviricide buildings are decorated with as much as 1,200 ligands, equivalent to peptides, that bind to viral glycoproteins. The micelles then fuse with the viral membrane, unfavorable it so that it could perhaps well now no longer infect a bunch cell.

The firm had been gearing up for a clinical trial of a topical nanoviricide for treating shingles, nonetheless last 365 days it pivoted to focal level on COVID-19. In March, it publicized sure outcomes from in vivo examine of two nanoviricides against SARS-CoV-2. To boot to its stylish mechanism of viral membrane disruption, one among the nanoviricides carried the antiviral molecule remdesivir in its core. Both nanoviricides a great deal prolonged survival conditions in rats with lethal coronavirus lung infections as when put next with remdesivir remedy by myself. Though these scrutinize outcomes bear no longer but been seek files from reviewed, the firm says it’s preparing to acquire the 2 nanoviricides into clinical trials.

Jackman is also constructing antiviral peptides, which slot into the viral membrane and aggregate to build pores. “As soon as a excessive choice of holes is fashioned in a membrane, it’s more or less like Swiss cheese, and it appropriate collapses,” says Jackman, who has conventional this approach to successfully style out lethal Zika virus in mice.

For now it’s accumulated early days for all of these technologies. “It’s a extremely niche space, nonetheless I judge it’s rising. And there could be for sure hobby in it,” says Kathie Seley-Radtke, a medicinal chemist on the College of Maryland, Baltimore County, who develops small-molecule antiviral brokers and is president-elect of the International Society for Antiviral Compare. “The backside line is, we are able to’t discard any possibility appropriate now, because COVID is so excessive.”

Jackman adds that pharma and biotech companies are veritably taking a cautious capacity to therapeutic nanomaterials. There are accumulated issues about bioaccumulation of the nanoparticles, to illustrate, and capability long-time length facet effects. Nonetheless he says the brand new progress with lipid nanoparticles in mRNA vaccines clearly reveals that nanomaterials could even be precious in tackling viruses, which could moreover simply bolster self perception.

One other barrier is that many of the in vivo examine on these materials bear conventional a diverse vary of protocols, making them sophisticated to examine. Some protocols involve preincubating the antiviral nanomaterial with the virus earlier than administering the combine to an animal, or giving the antiviral to the animal earlier than exposure to a virus. To lend a hand more nanomaterials switch into clinical trials, Jackman suggests that researchers desire to agree on standardized animal gadgets and efficiency benchmarks, and focal level on evaluating antiviral nanomaterials in animals which could well be infected with a virus first. “The topic fabric science is appropriate superior for all these concepts,” Jackman says. “I judge that the subsequent frontier is to if truth be told compose this more translational.”

Creator files


  1. Penrith, UK

    Stamp Peplow

About this article

Verify currency and authenticity via CrossMark

Cite this article

Peplow, M. Nanotechnology offers different ways to fight COVID-19 pandemic with antivirals.
Nat Biotechnol 39, 1172–1174 (2021).

Download citation

Read Extra

Leave a reply